Home / Search / Cell Type Identification / Expression / BLAST / Statistics / Download / Help
: marker.| Dataset ID | Tissue / Organ | Experiment type | Sample | Cell type | Marker class | Evidence | |
|---|---|---|---|---|---|---|---|
| PRJNA656271 (2dpf) | embryo | baseline | 2dpf, FACS-isolated EGFP+ cells | ||||
| PRJNA564810 (2dpf) | embryo | baseline | 2dpf, a single-cell transcriptome atlas for zebrafish development |
Neuroblast (cluster: 3) Neuron (cluster: 4) |
potential marker potential marker |
NA NA |
|
| PRJNA564810 (1dpf) | embryo | baseline | 1dpf, a single-cell transcriptome atlas for zebrafish development |
Neuroblast (cluster: 1) |
potential marker |
NA |
|
| PRJNA415636 (brain) | brain | baseline | adult, Zebrabow M, brain | ||||
| GSE158142 (8dpf) | brain, eye | baseline | 8dpf, untreatment | ||||
| GSE158142 (15dpf) | brain, eye | baseline | 15dpf, untreatment | ||||
| GSE151354 (wild type) | cartilage | baseline | 21dpf, wild type | ||||
| GSE151354 (nkx3.2 mutant) | cartilage | growth | 21dpf, nkx3.2 mutant | ||||
| PRJNA610520 (4.5dpf) | caudal hematopoietic tissue | baseline | 4.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. | ||||
| PRJNA610520 (3.5dpf) | caudal hematopoietic tissue | baseline | 3.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. | ||||
| PRJNA734348 (shield, dnmt1) | embryo | growth | 6hpf, shield, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV) | ||||
| PRJNA734348 (dome, control) | embryo | baseline | 4.3hpf, dome, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) | ||||
| PRJNA564810 (5dpf) | embryo | baseline | 5dpf, a single-cell transcriptome atlas for zebrafish development | ||||
| PRJNA706197 (1.25dpf) | embryo | baseline | 1.25dpf, FACS sorted sox10:nEOS cells | ||||
| PRJNA706197 (14hpf) | embryo | baseline | 14hpf, FACS sorted sox10:nEOS cells | ||||
| GSE158849 (unlabeled) | embryo | baseline | 6hpf, WT, 4sUTP injected (unlabeled) | ||||
| GSE173972 (WT, ezh1+|+) | embryo | baseline | 1.25dpf, Kdrl-positive embryos | ||||
| PRJNA656271 (24hpf) | embryo | baseline | 24hpf, FACS-isolated EGFP+ cells | ||||
| PRJNA734348 (dome, dnmt1) | embryo | growth | 4.3hpf, dome, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV) | ||||
| GSE126647 (control) | embryo | baseline | 1.17dpf, control nkx2.5:ZsYellow+ cells | ||||
| PRJNA706197 (18hpf) | embryo | baseline | 18hpf, FACS sorted sox10:nEOS cells | ||||
| PRJNA706197 (20hpf) | embryo | baseline | 20hpf, FACS sorted sox10:nEOS cells | ||||
| GSE106587 (WT) | embryo | baseline | 12hpf, 6 somites, wild-type TLAB embryo | ||||
| GSE173972 (HET, ezh1+|-) | embryo | hematopoietic | 1.25dpf, Kdrl-positive embryos | ||||
| PRJNA656271 (1.5dpf) | embryo | baseline | 1.5dpf, FACS-isolated EGFP+ cells | ||||
| PRJNA734348 (shield, control) | embryo | baseline | 6hpf, shield, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) | ||||
| GSE126647 (Pbx4-depleted) | embryo | growth | 1.17dpf, Pbx4-depleted nkx2.5:ZsYellow+ cells | ||||
| PRJNA706197 (24hpf) | embryo | baseline | 24hpf, FACS sorted sox10:nEOS cells | ||||
| GSE158849 (labeled) | embryo | baseline | 6hpf, WT, 4sUTP injected (labeled) | ||||
| PRJNA706197 (12hpf) | embryo | baseline | 12hpf, FACS sorted sox10:nEOS cells | ||||
| PRJNA640816 (2dpf) | embryo | baseline | 2dpf, FACS isolated -4.9sox10:EGFP+ cells | ||||
| GSE173972 (KO, ezh1-|-) | embryo | hematopoietic | 1.25dpf, Kdrl-positive embryos | ||||
| GSE158142 (20hpf) | head | baseline | 20hpf, 21-22 somites, untreatment | ||||
| GSE158142 (2dpf) | head | baseline | 2dpf, untreatment | ||||
| GSE158142 (14hpf) | head | baseline | 14hpf, 10 somites, untreatment | ||||
| GSE158142 (24hpf) | head | baseline | 24hpf, untreatment | ||||
| GSE158142 (16hpf) | head | baseline | 16hpf, 14 somites, untreatment | ||||
| GSE158142 (1.5dpf) | head | baseline | 1.5dpf, untreatment | ||||
| GSE158142 (18hpf) | head | baseline | 18hpf, 18 somites, untreatment | ||||
| GSE158142 (12hpf) | head | baseline | 12hpf, 6 somites, untreatment | ||||
| PRJNA608912 (kit_2dpi) | heart | regeneration | 5mpf, kit mutant, 2 days post injury | ||||
| PRJNA608912 (kit_7dpi) | heart | regeneration | 5mpf, kit mutant, 7 days post injury | ||||
| PRJNA608912 (wt_2dpi) | heart | regeneration | 5mpf, wild type, 2 days post injury | ||||
| PRJNA608912 (kit_uninjuried) | heart | regeneration | 5mpf, kit mutant, uninjured | ||||
| PRJNA605021 (supporting cells) | neuromast | baseline | 7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae | ||||
| PRJNA605021 (hair cells) | neuromast | baseline | 7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[myo6b:actb1-EGFP] transgenic zebrafish larvae | ||||
| PRJNA668529 (3h) | olfactory rosette | disease | 3mpf, intranasal 100ng r-Spike 3 hours | ||||
| PRJNA668529 (control) | olfactory rosette | baseline | 3mpf, intranasal PBS | ||||
| PRJNA668529 (3d) | olfactory rosette | disease | 3mpf, intranasal 100ng r-Spike 3 days | ||||
| PRJNA672101 (nrl-KO) | retina | growth | 5mpf, three retinas from nrl-KO zebrafsih | ||||
| GSE122680 (2dpf) | retina | baseline | 2dpf, WT, untreatment | ||||
| GSE122680 (1.5dpf) | retina | baseline | 1.5dpf, WT, untreatment | ||||
| GSE122680 (3dpf) | retina | baseline | 3dpf, WT, untreatment | ||||
| GSE122680 (14dpf) | retina | baseline | 14dpf, WT, untreatment | ||||
| GSE122680 (24hpf) | retina | baseline | 24hpf, WT, untreatment | ||||
| PRJNA551501 (2mpf) | thyroid gland | baseline | 2mpf, Tg(tg:mVenus-T2A-NTR) | ||||
| PRJNA551501 (8mpf) | thyroid gland | baseline | 8mpf, Tg(tg:mVenus-T2A-NTR) | ||||
| GSE152982 (wild type) | trunk | baseline | 1.25dpf, untreatment | ||||
| GSE131136 (all) | trunk, skin | baseline | 5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone | ||||
| PRJNA641144 (P_INV) | tumor | disease | adult, ZMEL1-INV cells in vivo primary tumors | ||||
| PRJNA641144 (C_PRO) | tumor | disease | adult, ZMEL1-PRO cells in vitro co-culture | ||||
| PRJNA641144 (D_INV) | tumor | disease | adult, ZMEL1-INV cells in vitro individual culture | ||||
| PRJNA641144 (P_PRO) | tumor | disease | adult, ZMEL1-PRO cells in vivo primary tumors | ||||
| PRJNA641144 (D_PRO) | tumor | disease | adult, ZMEL1-PRO cells in vitro individual culture | ||||
| PRJNA641144 (M_INV) | tumor | disease | adult, ZMEL1-INV cells in vivo metastases | ||||
| PRJNA641144 (C_INV) | tumor | disease | adult, ZMEL1-INV cells in vitro co-culture | ||||
| PRJNA641144 (M_PRO) | tumor | disease | adult, ZMEL1-PRO cells in vivo metastases | ||||
| GSE158099 (runx1 -|-) | whole body | hematopoietic | 10dpf, cd41:GFPlow-runx1-/- | ||||
| GSE158099 (WT) | whole body | baseline | 2.5dpf, cd41:GFPlow-WT | ||||
| GSE158099 (runx1 -|-) | whole body | hematopoietic | 16dpf, cd41:GFPlow-runx1-/- | ||||
| GSE158099 (runx1 -|-) | whole body | hematopoietic | 2.5dpf, cd41:GFPlow-runx1-/- | ||||
| GSE158099 (runx1 -|-) | whole body | hematopoietic | 6dpf, cd41:GFPlow-runx1-/- | ||||
| GSE158099 (runx1 -|-) | whole body | hematopoietic | 16dpf, cd41:GFPlow-runx1-/- |